Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Iomab-B |
| Trade Name | |
| Synonyms | I 131 MOAB BC8|131-I Apamistamab|Iodine I 131-apamistamab |
| Drug Descriptions |
Iomab-B (131-I apamistamab) comprises an antibody targeting CD45 conjugated to iodine 131 (I-131), which delivers I-131 to CD45-expressing cells, potentially resulting in increased death of CD45-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | 2097132-02-8 |
| NCIT ID | C2527 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Anti-CD19CAR-CD28-CD3zeta-EGFRt T-cells + Iomab-B | Anti-CD19CAR-CD28-CD3zeta-EGFRt T-cells Iomab-B | 0 | 1 |
| axicabtagene ciloleucel + Iomab-B | Iomab-B axicabtagene ciloleucel | 0 | 1 |
| Fludarabine + Iomab-B | Fludarabine Iomab-B | 0 | 1 |
| Iomab-B | Iomab-B | 0 | 0 |